• Issues
    • Current Issue
    • Special Issues
  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • Hematologica Obscura
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • HemOnc Link
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Search
  • ASH Home
  • About ASH Clinical News
  • Authors
  • Advertising
  • Subscribe
  • Contact Us
  • eNewsletters
  • Cookie Settings
  • LOG IN
Welcome! Log into your account
Forgot your password?
Recover your password
ASH Clinical News
  • Issues
    • AllCurrent IssueSpecial Issues

      June 2021 Volume 7 Issue 7

      May 2021 Volume 7 Issue 6

      Focus on Myeloid Malignancies (Volume 7, Issue 6.1)

      April 2021 Volume 7 Issue 5

  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • Hematologica Obscura
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • HemOnc Link
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
    Alisa Wolberg, PhD

    Alisa Wolberg, PhD

    Professor of Pathology, UNC Blood Research Center
    • 2020 ASH Annual Meeting Preview: Conversations With Co-Chairs Monday, November 16th, 2020

      Education Program Co-chairs

    Sabrina Ahle
    Advertisement

    Current Issue

    June 2021 Volume 7 Issue 7

    Tuesday, June 1, 2021
    This issue reviews the management and prevention of peripheral neuropathy, early successes of SCD screening programs in sub-Saharan Africa, and more.

    Block title

    R-CHOP Versus R-EPOCH: No Difference in Survival for Patients With MYC-Rearranged, Double- or Triple-Hit...

    Saturday, June 12, 2021

    Investigators Identify Distinct Molecular Subgroups to Guide Treatment Decisions in AML

    Saturday, June 12, 2021

    Evaluating Enasidenib, With or Without Azacitidine, in Patients with IDH2-Mutated MDS

    Saturday, June 12, 2021

    Masking, Vaccination, and Research Needed to Protect Our Most Vulnerable Against COVID-19

    Friday, June 11, 2021

    Fixed-Duration Ibrutinib, Venetoclax Oral Combination Effective in CLL/SLL

    Tuesday, June 8, 2021
    Recent Posts
    • R-CHOP Versus R-EPOCH: No Difference in Survival for Patients With MYC-Rearranged, Double- or Triple-Hit DLBCL
    • Investigators Identify Distinct Molecular Subgroups to Guide Treatment Decisions in AML
    • Evaluating Enasidenib, With or Without Azacitidine, in Patients with IDH2-Mutated MDS
    • Masking, Vaccination, and Research Needed to Protect Our Most Vulnerable Against COVID-19

    Meeting Coverage

    Researchers Validate Burkitt Lymphoma Prognostic Index

    Monday, March 1, 2021

    Thiotepa-Containing Conditioning Regimens Improve Survival Outcomes in Patients With PCNSL

    Monday, March 1, 2021

    Editor's Corner

    Editor’s Corner: It Takes a Village

    Tuesday, June 1, 2021

    Editor’s Corner: All Those YESterdays

    Saturday, May 1, 2021
    2021 L Street NW, Suite 900, Washington, DC 20036
    Phone 202-776-0544 | Fax 202-776-0545
    • ASH Home
    • Research
    • Education
    • Advocacy
    • Meetings
    • Publications
    • ASH Store
    Copyright © 2020 by American Society of Hematology

    Contact Us | Terms of Service | Privacy Policy